Intrahepatic cholangiocarcinoma: Its mode of spreading and therapeutic modalities

Ken Shirabe, Mitsuo Shimada, Norifumi Harimoto, Keishi Sugimachi, Yo Ichi Yamashita, Eiji Tsujita, Shin Ichi Aishima

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Intrahepatic cholangiocarcinoma (IHCC) is a primary adenocarcinoma of the liver, arising from the intrahepatic bile ducts. The prognosis is generally poor because locoregional extension is usually advanced at the time of diagnosis. Even after a resection, the outcome for patients with advanced IHCC is extremely poor, and the presence of lymph node metastasis has been reported in most previous studies to be the worst prognostic factor after a resection. There are no clear guidelines on lymph node dissection with IHCC. In this article, we review the mode of invasion and the therapeutic modalities: hepatic resection, lymph node dissection, liver transplantation, radiation, and chemotherapy for IHCC.

Original languageEnglish
Pages (from-to)S159-S164
JournalSurgery
Volume131
Issue number1 SUPPL.
DOIs
Publication statusPublished - Jan 1 2002

Fingerprint

Cholangiocarcinoma
Lymph Node Excision
Intrahepatic Bile Ducts
Liver
Therapeutics
Liver Transplantation
Adenocarcinoma
Lymph Nodes
Guidelines
Radiation
Neoplasm Metastasis
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Shirabe, K., Shimada, M., Harimoto, N., Sugimachi, K., Yamashita, Y. I., Tsujita, E., & Aishima, S. I. (2002). Intrahepatic cholangiocarcinoma: Its mode of spreading and therapeutic modalities. Surgery, 131(1 SUPPL.), S159-S164. https://doi.org/10.1067/msy.2002.119498

Intrahepatic cholangiocarcinoma : Its mode of spreading and therapeutic modalities. / Shirabe, Ken; Shimada, Mitsuo; Harimoto, Norifumi; Sugimachi, Keishi; Yamashita, Yo Ichi; Tsujita, Eiji; Aishima, Shin Ichi.

In: Surgery, Vol. 131, No. 1 SUPPL., 01.01.2002, p. S159-S164.

Research output: Contribution to journalArticle

Shirabe, K, Shimada, M, Harimoto, N, Sugimachi, K, Yamashita, YI, Tsujita, E & Aishima, SI 2002, 'Intrahepatic cholangiocarcinoma: Its mode of spreading and therapeutic modalities', Surgery, vol. 131, no. 1 SUPPL., pp. S159-S164. https://doi.org/10.1067/msy.2002.119498
Shirabe K, Shimada M, Harimoto N, Sugimachi K, Yamashita YI, Tsujita E et al. Intrahepatic cholangiocarcinoma: Its mode of spreading and therapeutic modalities. Surgery. 2002 Jan 1;131(1 SUPPL.):S159-S164. https://doi.org/10.1067/msy.2002.119498
Shirabe, Ken ; Shimada, Mitsuo ; Harimoto, Norifumi ; Sugimachi, Keishi ; Yamashita, Yo Ichi ; Tsujita, Eiji ; Aishima, Shin Ichi. / Intrahepatic cholangiocarcinoma : Its mode of spreading and therapeutic modalities. In: Surgery. 2002 ; Vol. 131, No. 1 SUPPL. pp. S159-S164.
@article{50f43521b65b45f29929a4e363667a44,
title = "Intrahepatic cholangiocarcinoma: Its mode of spreading and therapeutic modalities",
abstract = "Intrahepatic cholangiocarcinoma (IHCC) is a primary adenocarcinoma of the liver, arising from the intrahepatic bile ducts. The prognosis is generally poor because locoregional extension is usually advanced at the time of diagnosis. Even after a resection, the outcome for patients with advanced IHCC is extremely poor, and the presence of lymph node metastasis has been reported in most previous studies to be the worst prognostic factor after a resection. There are no clear guidelines on lymph node dissection with IHCC. In this article, we review the mode of invasion and the therapeutic modalities: hepatic resection, lymph node dissection, liver transplantation, radiation, and chemotherapy for IHCC.",
author = "Ken Shirabe and Mitsuo Shimada and Norifumi Harimoto and Keishi Sugimachi and Yamashita, {Yo Ichi} and Eiji Tsujita and Aishima, {Shin Ichi}",
year = "2002",
month = "1",
day = "1",
doi = "10.1067/msy.2002.119498",
language = "English",
volume = "131",
pages = "S159--S164",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Intrahepatic cholangiocarcinoma

T2 - Its mode of spreading and therapeutic modalities

AU - Shirabe, Ken

AU - Shimada, Mitsuo

AU - Harimoto, Norifumi

AU - Sugimachi, Keishi

AU - Yamashita, Yo Ichi

AU - Tsujita, Eiji

AU - Aishima, Shin Ichi

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Intrahepatic cholangiocarcinoma (IHCC) is a primary adenocarcinoma of the liver, arising from the intrahepatic bile ducts. The prognosis is generally poor because locoregional extension is usually advanced at the time of diagnosis. Even after a resection, the outcome for patients with advanced IHCC is extremely poor, and the presence of lymph node metastasis has been reported in most previous studies to be the worst prognostic factor after a resection. There are no clear guidelines on lymph node dissection with IHCC. In this article, we review the mode of invasion and the therapeutic modalities: hepatic resection, lymph node dissection, liver transplantation, radiation, and chemotherapy for IHCC.

AB - Intrahepatic cholangiocarcinoma (IHCC) is a primary adenocarcinoma of the liver, arising from the intrahepatic bile ducts. The prognosis is generally poor because locoregional extension is usually advanced at the time of diagnosis. Even after a resection, the outcome for patients with advanced IHCC is extremely poor, and the presence of lymph node metastasis has been reported in most previous studies to be the worst prognostic factor after a resection. There are no clear guidelines on lymph node dissection with IHCC. In this article, we review the mode of invasion and the therapeutic modalities: hepatic resection, lymph node dissection, liver transplantation, radiation, and chemotherapy for IHCC.

UR - http://www.scopus.com/inward/record.url?scp=0036160991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036160991&partnerID=8YFLogxK

U2 - 10.1067/msy.2002.119498

DO - 10.1067/msy.2002.119498

M3 - Article

C2 - 11821804

AN - SCOPUS:0036160991

VL - 131

SP - S159-S164

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 1 SUPPL.

ER -